Literature DB >> 20592613

Female bladder cancer: incidence, treatment, and outcome.

Emil Scosyrev1, Deep Trivedi, Edward Messing.   

Abstract

PURPOSE OF REVIEW: Women are generally less likely to develop bladder cancer compared with men; however, once they acquire this disease, they have a less favorable prognosis. In this review, we describe our current understanding of the relationship between sex and bladder cancer incidence and outcomes and discuss the most recent developments in this area of research. RECENT
FINDINGS: Despite some evidence suggesting involvement of hormonal factors in bladder cancer carcinogenesis, the exact mechanisms responsible for increased bladder cancer incidence in men are still incompletely understood. The causes of increased mortality in women are also unclear. It has been hypothesized that women present with more advanced stages (and thus have inferior survival) than men because early signs of bladder cancer in women are often attributed to more common benign conditions. However, recent studies have shown that excess mortality in women persists after adjustment for stage and other tumor characteristics. Women also do not appear to be significantly undertreated for bladder cancer.
SUMMARY: Despite considerable research efforts, both increased incidence in men and decreased survival in women remain somewhat of a mystery. The causes of these phenomena may include poorly understood biological factors or environmental influences, which may become a subject of future research.

Entities:  

Mesh:

Year:  2010        PMID: 20592613     DOI: 10.1097/MOU.0b013e32833c7a9b

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  9 in total

1.  Gender-dependent cancer-specific survival following radical cystectomy.

Authors:  Matthias May; Christian Stief; Sabine Brookman-May; Wolfgang Otto; Christian Gilfrich; Jan Roigas; Mario Zacharias; Wolf F Wieland; Hans-Martin Fritsche; Ferdinand Hofstädter; Maximilian Burger
Journal:  World J Urol       Date:  2011-10-09       Impact factor: 4.226

2.  Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer.

Authors:  F Santos; A Dragomir; W Kassouf; E Franco; A Aprikian
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

3.  Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.

Authors:  C-H Tseng
Journal:  Diabetologia       Date:  2011-05-05       Impact factor: 10.122

4.  Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation.

Authors:  Joshua A Cohn; Benjamin Vekhter; Christopher Lyttle; Gary D Steinberg; Michael C Large
Journal:  Cancer       Date:  2013-11-13       Impact factor: 6.860

5.  Prognostic value of sex-hormone receptor expression in non-muscle-invasive bladder cancer.

Authors:  Jong Kil Nam; Sung Woo Park; Sang Don Lee; Moon Kee Chung
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

6.  Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies.

Authors:  Hiroki Ide; Satoshi Inoue; Hiroshi Miyamoto
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

7.  Exploring trends in advanced bladder cancer using the NCDB: turning data into information and information into insight.

Authors:  Niluja Thiruthaneeswaran; Ananya Choudhury
Journal:  Transl Androl Urol       Date:  2018-08

8.  Bladder cancer: a simple model becomes complex.

Authors:  Giovanni Battista Di Pierro; Caterina Gulia; Cristiano Cristini; Giorgio Fraietta; Lorenzo Marini; Pietro Grande; Vincenzo Gentile; Roberto Piergentili
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

Review 9.  Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor.

Authors:  Hiroki Ide; Hiroshi Miyamoto
Journal:  Dis Markers       Date:  2015-12-07       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.